BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weber F. Interaction of hepatitis C virus with the type I interferon system. World J Gastroenterol 2007; 13(36): 4818-4823 [PMID: 17828812 DOI: 10.3748/wjg.v13.i36.4818]
URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4818.htm
Number Citing Articles
1
Martin Probst, Christoph Hoeller, Peter Ferenci, Albert F. Staettermayer, Sandra Beinhardt, Hubert Pehamberger, Harald Kittler, Katharina Grabmeier-Pfistershammer, Andrzej T. Slominski. IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with MelanomaPLoS ONE 2014; 9(11): e112613 doi: 10.1371/journal.pone.0112613
2
Sanja Matic, Dragan Milovanovic, Zeljko Mijailovic, Predrag Djurdjevic, Predrag Sazdanovic, Srdjan Stefanovic, Danijela Todorovic, Suzana Popovic, Katarina Vitosevic, Vladimir Vukicevic, Milena Vukic, Nenad Vukovic, Nevena Milivojevic, Marko Zivanovic, Vladimir Jakovljevic, Nenad Filipovic, Natasa Djordjevic, Dejan Baskic. Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in femalesJournal of Medical Virology 2023; 95(10) doi: 10.1002/jmv.29152
3
Takuya Kuwashiro, Shinji Iwane, Xia Jinghe, Sachiko Matsuhashi, Yuichiro Eguchi, Keizo Anzai, Kazuma Fujimoto, Toshihiko Mizuta, Naoya Sakamoto, Masanori Ikeda, Nobuyuki Kato, Iwata Ozaki. Regulation of interferon signaling and HCV‑RNA replication by extracellular matrixInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3693
4
Ying Wang, Shan-Shan Mao, Qiong-Qiong He, Yuan Zi, Ji-Fang Wen, De-Yun Feng. Specific activation of 2'-5'oligoadenylate synthetase gene promoter by hepatitis C virus-core protein: A potential for developing hepatitis C virus targeting gene therapyWorld Journal of Gastroenterology 2009; 15(25): 3178-3182 doi: 10.3748/wjg.15.3178
5
Erika A. Eksioglu, Haizhen Zhu, Lilly Bayouth, Jennifer Bess, Hong-yan Liu, David R. Nelson, Chen Liu, Jean-Luc E. P. H. Darlix. Characterization of HCV Interactions with Toll-Like Receptors and RIG-I in Liver CellsPLoS ONE 2011; 6(6): e21186 doi: 10.1371/journal.pone.0021186
6
Amy D. Proal, Michael B. VanElzakker. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent SymptomsFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.698169
7
Yanni Chen, Junbo Chen, Hui Wang, Jingjing Shi, Kailang Wu, Shi Liu, Yingle Liu, Jianguo Wu, Charles M. Rice. HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1PLoS Pathogens 2013; 9(4): e1003248 doi: 10.1371/journal.ppat.1003248
8
Yuan Liu, Ziying Zou, Bing Zhu, Zonghai Hu, Ping Zeng, Lijuan Wu. LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in HepatocytesHepatitis Monthly 2015; 15(5) doi: 10.5812/hepatmon.15(5)2015.28473
9
Rebekka J.S. Salzmann, Christina Krötz, Tudor Mocan, Lavinia P. Mocan, Cristiana Grapa, Sophia Rottmann, Ramona Reichelt, Cindy M. Keller, Bettina Langhans, Frederik Schünemann, Alexander Pohl, Thomas Böhler, Käthe Bersiner, Marcin Krawczyk, Piotr Milkiewicz, Zeno Sparchez, Frank Lammert, Sebastian Gehlert, Maria A. Gonzalez-Carmona, Arnulf Willms, Christian P. Strassburg, Miroslaw T. Kornek, Leona Dold, Veronika Lukacs-Kornek. Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitisHepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000380